Pancreatic Beta-Cell Function and Type 2 Diabetes Risk: Quantify the Causal Effect Using a Mendelian Randomization Approach Based on Meta-Analyses

Yiqing Song,Edwina Yeung,Aiyi Liu,Tyler J. VanderWeele,Liwei Chen,Chen Lu,Chunling Liu,Enrique F. Schisterman,Yi Ning,Cuilin Zhang

DOI: https://doi.org/10.1093/hmg/dds339

2012-01-01

Abstract:The objective of the study is to quantify the causal effect of -cell function on type 2 diabetes by minimizing residual confounding and reverse causation. We employed a Mendelian randomization (MR) approach using TCF7L2 variant rs7903146 as an instrument for lifelong levels of -cell function. We first conducted two sets of meta-analyses to quantify the association of the TCF7L2 variant with the risk of type 2 diabetes among 55 436 cases and 106 020 controls from 66 studies by calculating pooled odds ratio (OR) and to quantify the associations with multiple direct or indirect measures of -cell function among 35 052 non-diabetic individuals from 31 studies by calculating pooled mean difference. We further applied the method of MR to obtain the causal estimates for the effect of -cell function on type 2 diabetes risk based on findings from the meta-analyses. The OR [95 confidence interval (CI)] was 0.87 (0.810.93) for each five unit increment in homeostasis model assessment of insulin secretion (HOMA-B) (P 3.0 10(5)). In addition, for measures based on intravenous glucose tolerance test, ORs (95 CI) associated with type 2 diabetes risk were 0.24 (0.080.74) (P 0.01) and 0.14 (0.040.48) (P 0.002) for per 1 standard deviation increment in insulin sensitivity index and disposition index, respectively. Findings from the present study lend support to a causal role of pancreatic -cell function itself in the etiology of type 2 diabetes.